Rabeprazole‐amoxicillin dual therapy as first‐line treatment for H pylori eradication in special patients: A retrospective, real‐life study

BACKGROUND: The currently recommended quadruple regimens for Helicobacter pylori infection might not be appropriate for every patient, especially in elderly patients or those with multiple comorbidities. OBJECTIVE: To evaluate the efficacy and safety of rabeprazole‐amoxicillin dual therapy in H pylo...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Wen, Ye, Hui, Deng, Xin, Wang, Chi, Xu, Ying, Li, Yixuan, Zhang, Xuezhi, Cheng, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540066/
https://www.ncbi.nlm.nih.gov/pubmed/32548932
http://dx.doi.org/10.1111/hel.12717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540066/
https://www.ncbi.nlm.nih.gov/pubmed/32548932
http://dx.doi.org/10.1111/hel.12717

Ejemplares similares